<!DOCTYPE html>
<html lang="en">


<!-- Mirrored from www.radiantpharmabd.com/products/101/details by HTTrack Website Copier/3.x [XR&CO'2014], Sat, 16 Apr 2022 19:25:43 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=UTF-8" /><!-- /Added by HTTrack -->
<head>

    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="description" content="">
    <meta name="author" content="Impala Intech Ltd.">

    <title>Radiant Pharmaceuticals Limited</title>

    <!-- Bootstrap core CSS -->
    <link href="../../css/front-end/bootstrap.min.css" rel="stylesheet">
    <link href="../../css/front-end/fontawesome.all.min.css" rel="stylesheet">
    <link href="../../css/front-end/slick.min.css" rel="stylesheet">
    <link href="../../css/front-end/aos.css" rel="stylesheet">
    <link rel="shortcut icon" href="../../images/fav_icon.png" type="image/x-icon">

    <link href="https://fonts.googleapis.com/css?family=Lato:300,400,700,300italic,400italic,700italic" rel="stylesheet"
        type="text/css">

    <!-- Custom styles for this template -->
    <link href="../../css/front-end/main.css" rel="stylesheet">

    <link href="../../purecookie.css" rel="stylesheet">
    <script src="../../purecookie.js"></script>

    <link href="../../css/front-end/product.css" rel="stylesheet">
<style>
    .pd-header {
        /*padding-top: 110px;*/
    }
    .pd-basic-info {
        min-height: 440px;
        padding: 10px;
        display: flex;
        flex-direction: column;
    }
    .slider-container {
        border: none;
        border-radius: 0;
        box-shadow: 0 0 10px #0000001c;
    }
    .info-wrapper {
        display: flex;
        flex-direction: column;
        justify-content: space-evenly;
        height: 100%;
    }
    .info-wrapper > div:last-of-type {
        flex: 1;
        display: flex;
        flex-direction: column;
        justify-items: center;
        justify-content: flex-end;
    }
    .info-wrapper > div:first-of-type {
        margin-bottom: -15px;
    }

    .pd-basic-info .title,
    .pd-basic-info .desc {
        font-size: 14px;
        margin-left: 0;
    }

    .pd-basic-info .title {
        margin-top: 15px;
    }

    .pd-basic-info .btn {
        margin: 0;
        display: block;
    }
    .pd-basic-info > .info-wrapper > div:first-of-type > img {
        width: 70%;
    }

</style>


    <script>
        // popup title
        var purecookieTitle = "Cookies.";
        // popup content
        var purecookieDesc = "This website can be browsed without submitting any personal information. If anyone is willing to share any such information, in that case, we may preserve that information, and it will be kept confidential unless it is subject to disclosure due to regulatory obligation. Personal information will not be used for any commercial purposes";
        // policy link
        var purecookieLink = '';
        // button text
        var purecookieButton = "Understood";
    </script>
</head>

<body>

    <!--===== Preloader =====-->
    <div class="preloader d-flex align-items-center justify-content-center"><div class="lds-ripple"><div></div><div></div></div></div>
    <!--===== End Preloader =====-->

    <!-- Navigation Top -->
    <div class="topbar">
    <div class="container">
        <div class="d-flex justify-content-end">
            <div class="topbar-right d-flex align-items-center justify-content-end h-100 wow fadeInRight">
                <a class="" href="../../pharmacovigilance.html">Pharmacovigilance</a>
                <a href="../../csr-our-commitment.html">CSR</a>
                <a class="" href="../../career.html">Career</a>
                <a class="" href="../../contact-us.html">Contact Us</a>
            </div>
        </div>
    </div>
</div>

    <!-- #header -->
    <header id="header">
    <div class="container d-flex align-items-center justify-content-between">
        <div id="logo" class="pull-left">
            <!-- <h1><a href="#intro" class="scrollto">Radiant</a></h1> -->
            <a href="../../index.html"><img src="../../images/logo.png" alt="" title=""></a>
        </div>






        <!--main-nav-->
        <nav id="nav-menu-container">
    <ul class="nav-menu" data-responsive-menu="991">
        <li class="menu-active">
            <a href="../../about-us.html">About Us</a>
            <ul>
                <li>
                    <a class="n-btn n-btn-2" href="../../about-us.html"><span>-</span> Overview</a>
                </li>
                <li>
                    <a class="n-btn n-btn-2" href="../../mission.html"><span>-</span> Mission, Vision & Core Value</a>
                </li>
                <li>
                    <a class="n-btn n-btn-2" href="../../history.html"><span>-</span> History</a>
                </li>
                <li>
                    <a class="n-btn n-btn-2" href="../../meet-our-chairman.html"><span>-</span> Meet Our Chairman</a>
                </li>
            </ul>
        </li>

        <li>
            <a href="../../products.html">Products</a>
            <ul>
                
                <li><a href="../../products.html"><span>-</span> Brand Name </a></li>
                <li><a href="../generics.html"><span>-</span> Generic Name</a></li>
                <li><a href="../therapeutics.html"><span>-</span> Therapeutic Class </a></li>
            </ul>
        </li>

        <li>
            <a href="../../sustainability.html">Sustainability</a>
            <ul>
                <li>
                    <a class="n-btn n-btn-2" href="../../sustainability.html"><span>-</span> Overview</a>
                </li>
            </ul>
        </li>

        <li>
            <a href="#">Manufacturing Facilities</a>
            <ul>
              <li>
                <a class="n-btn n-btn-2" href="../../manufacturing.html"><span>-</span> Overview</a>
              </li>
              <li>
                <a class="n-btn n-btn-2" href="../../product-development.html"><span>-</span> Product Development</a>
              </li>
              <li>
                <a class="n-btn n-btn-2" href="../../production-facilities.html"><span>-</span> Production</a>
              </li>
              <li>
                <a class="n-btn n-btn-2" href="../../quality-control-facilities.html"><span>-</span> Quality Control</a>
              </li>
              <li>
                <a class="n-btn n-btn-2" href="../../engineering-facilities.html"><span>-</span> Engineering</a>
              </li>
              <li>
                <a class="n-btn n-btn-2" href="../../warehouse-facilities.html"><span>-</span> Warehouse</a>
              </li>
              <li>
                <a class="n-btn n-btn-2" href="../../quality-management-system.html"><span>-</span> Quality Management System</a>
              </li>
              <li>
                <a class="n-btn n-btn-2" href="../../safety-health-environment.html"><span>-</span> Safety, Health & Environment</a>
              </li>
              
            </ul>
          </li>

        <li>
            <a href="#">Global Amplification</a>
            <ul>
                <li class="menu-has-children"><a href="#">International Business</a>
                    <ul>
                        <li>
                            <a class="n-btn n-btn-2"
                                href="../../international-business-overview.html"><span>-</span> Overview</a>
                        </li>
                        <li>
                            <a class="n-btn n-btn-2" href="../../international-business-products.html"><span>-</span> Product
                                List</a>
                        </li>
                        <li>
                            <a class="n-btn n-btn-2" href="../../international-business-exports.html"><span>-</span> Export
                                Overview</a>
                        </li>
                        <li>
                            <a class="n-btn n-btn-2" href="../../international-business-grade-of-api.html"><span>-</span> Grade
                                of API</a>
                        </li>
                    </ul>
                </li>
                <li class="menu-has-children"><a href="#">Global Reach & Certifications</a>
                    <ul>
                        <li>
                            <a class="n-btn n-btn-2" href="../../global-reach.html"> <span>-</span> Global Reach</a>
                        </li>
                        <li>
                            <a class="n-btn n-btn-2" href="../../certification.html"> <span>-</span> Certifications</a>
                        </li>
                    </ul>
                </li>
                <li>
                    <a class="n-btn n-btn-2" href="../../contract-manufacturing-opportunities.html"> <span>-</span> Contract Manufacturing
                        Opportunities</a>
                </li>
            </ul>
        </li>





    </ul>

    <div class="menu-toggle">
        <p></p>
        <p></p>
        <p></p>
    </div>

</nav><!-- #nav-menu-container -->
    </div>
    <div class="mobile-menu" id="mobile-menu"></div>
    <div class="collapse" id="search-input-nav">
        <div class="row justify-content-md-center">
            <div class="col-8">
                <div class="search-wrapper grey-border" style="margin-bottom: 40px; margin-top: 50px;">
                    <input type="text" placeholder="Search">
                    <i class="fas fa-search"></i>
                </div>
            </div>
        </div>
    </div>
</header>

    <!-- Content Area -->
    <section class="pd-header">
    <div class="container">
        <div class="row justify-content-md-center">
            <div class="col-md-8 flex-grow-1">
                <div class="card slider-container mb-3 mb-md-0">
                    <div class="card-body">
                        <div class="pd-gallery">
                            <div id="slider1" class="carousel slide" data-ride="carousel">
                                <ol class="carousel-indicators">
                                                                                                            <li data-target="#slider1"
                                        style="background-image: url('../../storage/products/Dormicum__IMG_9841.jpg');"
                                        data-slide-to="0" class="active">
                                    </li>
                                                                        <li data-target="#slider1"
                                        style="background-image: url('../../storage/products/Dormicum__IMG_9842.jpg');"
                                        data-slide-to="1" class="">
                                    </li>
                                                                                                        </ol>
                                <div class="carousel-inner">
                                                                                                            <div class="carousel-item active" data-interval="4000">
                                        
                                        <img src="../../storage/products/Dormicum__IMG_9841.jpg" class="d-block center">
                                    </div>
                                                                        <div class="carousel-item " data-interval="4000">
                                        
                                        <img src="../../storage/products/Dormicum__IMG_9842.jpg" class="d-block center">
                                    </div>
                                                                                                        </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="col-md-4 flex-grow-1">
                <div class="pd-basic-info">
                    <div class="info-wrapper flex-grow-1">
                        <div>
                            <img src="../../storage/products/logos/Dormicum_Dormicum.svg" class="d-block">
                        </div>
                        
                        <div>
                            <div>
                                <p class="title">Generic</p>
                                <p class="desc">Midazolam</p>
                            </div>
                            <div>
                                <p class="title">Therapeutic Class</p>
                                <p class="desc"> Central nervous system (CNS)</p>
                            </div>
                            <div>
                                <p class="title">Pack Size</p>
                                <p class="desc">Dormicum 7.5 mg tablet: Each box contains 30 tablets (3 x 10's) in Alu-PVC blister pack.</p>
                            </div>
                        </div>
                        <div>
                            <a class="btn btn-primary" download href="../../storage/products/inserts/Dormicum_Dormicum_insert.pdf" role="button">
                                View Product Insert
                                <img src="../../storage/assets/download.png" class="float-right">
                            </a>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>
</section>

<section class="pd-info d-none">
    <div class="container">
        <div class="row justify-content-md-center">
                            <div class="col-12">
                    <h4 class="ac-header">Indications</h4>
                </div>
                <div class="col-12 ac-body">
                    Therapeutic Indications - Short-term treatment of insomnia. Benzodiazepines are only indicated when the disorder is severe, disabling or subjecting the individual to extreme distress. Sedation in premedication before surgical or diagnostic procedures.
                </div>
            
                            <div class="col-12">
                    <h4 class="ac-header">Therapeutic Class</h4>
                </div>
                <div class="col-12 ac-body">
                    Central nervous system (CNS)
                </div>
            
                            <div class="col-12">
                    <h4 class="ac-header">Dosage &amp; Administration</h4>
                </div>
                <div class="col-12 ac-body">
                    Dosage and Administration  Duration of treatment should be as short as possible. Generally the duration of treatment varies from a few days to a maximum of 2 weeks. The tapering-off process should be tailored to the individual. Treatment with DormicumÂ® should not be terminated abruptly (see 2.4.2 Drug Abuse and Dependence). In certain cases extension beyond the maximum treatment period may be necessary; if so, it should not take place without reevaluation of the patientâ€™s status. Owing to the rapid onset of action DormicumÂ® tablets should be taken immediately before going to sleep, and swallowed whole with fluid. DormicumÂ® can be taken at any time of the day, provided the patient is subsequently assured of at least 7-8 hours undisturbed sleep. Standard Dosage Dosage range: 7.5-15 mg. Treatment should be started with the lowest recommended dose. The maximum dose should not be exceeded because of the increased risk of CNS adverse effects possibly including clinically relevant respiratory and cardiovascular depression. Premedication: In premedication, DormicumÂ® should be given 30-60 minutes before the procedure. Special Dosage Instructions: Elderly and/or debilitated patients: In elderly and/or debilitated patients the recommended dose is 7.5 mg. Elderly patients showed a larger sedative effect, therefore they may be at increased risk of cardio-respiratory depression as well. Thus, DormicumÂ® should be used very carefully in elderly patients, and if needed, a lower dose should be considered. Patients with hepatic impairment: Patients with severe hepatic impairment should not be treated with DormicumÂ® (see section 2.3 Contraindications). In patients with mild to moderate hepatic impairment, the lowest dose possible should be considered, not exceeding 7.5 mg. (see 3.2.5 Pharmacokinetics in Special Populations). Patients with renal impairment: In patients with severe renal impairment, DormicumÂ® may be accompanied by more pronounced and prolonged sedation, possibly including clinically relevant respiratory and cardiovascular depression. DormicumÂ® should therefore be dosed carefully in this patient population and titrated for the desired effect. The lowest dose should be considered, not exceeding 7.5 mg (see 3.2.5 Pharmacokinetics in Special Populations).
                </div>
            
                            <div class="col-12">
                    <h4 class="ac-header">Contraindications</h4>
                </div>
                <div class="col-12 ac-body">
                    DormicumÂ® must not be used in patients with:

    Severe respiratory insufficiency.
    Severe hepatic impairment (benzodiazepines are not indicated to treat patients with severe hepatic impairment as they may cause encephalopathy).
    Sleep apnea syndrome.
    Known hypersensitivity to benzodiazepines or to any of their formulation excipients. Myasthenia gravis.

DormicumÂ® tablets should not be given to children, 12 years of age and under, because the available strengths of tablets do not allow for appropriate dosing in this patient population. DormicumÂ® tablets should not be given to patients receiving concomitant therapy with very strong CYP3A inducers or inhibitors (ketoconazole, itraconazole, voriconazole, HIV protease inhibitors including ritonavir-boosted formulations, and the HCV protease inhibitors boceprevir and telaprevir (see 2.4.5 Interactions with other Medicinal Products and other Forms of Interaction).
                </div>
            
                            <div class="col-12">
                    <h4 class="ac-header">Side Effects</h4>
                </div>
                <div class="col-12 ac-body">
                    Clinical Trials No text. Laboratory Abnormalities No text. Post-Marketing Immune System Disorders: Hypersensitivity reactions and angioedema may occur in susceptible individuals. Psychiatric Disorders: Confusional state, disorientation, emotionaland mood disturbances. These phenomena occur predominantly at the start of therapy and usually disappear with repeated administration. Changes in libido have been reported occasionally. Depression: pre-existing depression may be unmasked during benzodiazepine use. Paradoxical reactions such as restlessness, agitation, hyperactivity, nervousness, anxiety, irritability, aggressiveness, anger, nightmares, abnormal dreams, hallucinations, inappropriate behaviour and other adverse behavioural effects are known to occur. Should this be the case, use of the drug should be discontinued. These effects are more likely to occur in the elderly. Dependence: Use (even at therapeutic doses) may lead to the development of physical dependence. Abrupt discontinuation of the therapy may result in withdrawal or rebound phenomena including rebound insomnia, mood changes, anxiety and restlessness {see 2.4.1 General (Warnings and Precautions)}. Psychological drug dependence may occur. Abuse has been reported in poly-drug abusers. Nervous System Disorders: Drowsiness during the day, headache, dizziness, decreased alertness, ataxia. These phenomena occur predominantly at the start of therapy and usually disappear with repeated administration. When used as premedication, this product may contribute to postoperative sedation. Anterograde amnesia may occur with therapeutic doses, the risk increasing at higher dosages. Amnestic effects may be associated with inappropriate behaviour {see 2.4.1 General (Warnings and Precautions)}. Eye Disorders: Diplopia, this phenomenon occurs predominantly at the start of therapy and usually disappears with repeated administration. Gastrointestinal Disorders: Gastrointestinal disturbances, have been reported occasionally. Skin and Subcutaneous Tissue Disorders: Skin reactions have been reported occasionally. Musculoskeletal and Connective Tissue Disorders: Muscle weakness, this phenomenon occurs predominantly at the start of therapy and usually disappears with repeated administration. General Disorders and Administration Site Conditions: Fatigue, this phenomenon occurs predominantly at the start of therapy and usually disappear with repeated administration. Injury, Poisoning and Procedural Complications: There have been reports of falls and fractures in benzodiazepine users. The risk is increased in those taking concomitant sedatives (including alcoholic beverages) and in the elderly. Respiratory Disorders: Respiratory depression was reported. Cardiac Disorders: Cardiac failure including cardiac arrest was reported. Laboratory Abnormalities No text
                </div>
            
                            <div class="col-12">
                    <h4 class="ac-header">Pregnancy &amp; Lactation</h4>
                </div>
                <div class="col-12 ac-body">
                    Pregnancy: Insufficient data are available on midazolam to assess its safety during pregnancy. Benzodiazepines should be avoided during pregnancy unless there is no safer alternative. An increased risk of congenital malformation associated with the use of benzodiazepines during the first trimester of pregnancy has been suggested. If the product is prescribed to a woman of childbearing potential, she should contact her physician regarding discontinuation of the product if she intends to become or suspects that she is pregnant. The administration of midazolam in the last trimester of pregnancy or at high doses during labour has been reported to produce irregularities in the foetal heart rate, hypotonia, poor sucking and hypothermia and moderate respiratory depression in the neonate. Moreover, infants born to mothers who took benzodiazepines chronically during the latter stages of pregnancy may have developed physical dependence and may be at some risk of developing withdrawal symptoms in the postnatal period. Nursing Mothers Since midazolam passes into breast milk, DormicumÂ® should not be administered to breast-feeding mothers. Pediatric Use See Contraindications. Geriatric Use See Special Dosage Instructions and General (Warning and Precautions). Renal Impairment There is a greater likelihood of adverse drug reactions in patients with severe kidney disease. (see Special Dosage Instructions and Pharmacokinetics in Special Populations). Hepatic Impairment See Special Dosage Instructions and Contraindications.
                </div>
            
                            <div class="col-12">
                    <h4 class="ac-header">Precautions</h4>
                </div>
                <div class="col-12 ac-body">
                    General: Information should be given to the patients about following warnings and precautions. Tolerance: Some loss of efficacy to the hypnotic effects of short-acting benzodiazepines may develop after repeated use for a few weeks. Duration of treatment: The duration of treatment with benzodiazepine hypnotics should be as short as possible (see 2.2 Dosage and Administration), and should not exceed 2 weeks. The tapering-off process should be tailored to the individual. Extension beyond this period should not take place without reevaluation of the situation. Rebound insomnia: When discontinuing DormicumÂ® therapy, insomnia may reoccur, possibly with a higher severity than before starting treatment (â€œrebound insomniaâ€). Rebound insomnia, a transient syndrome, may be accompanied by other reactions including mood changes, anxiety, and restlessness. The risk of rebound phenomena is greater after abrupt discontinuation of treatment. Therefore it is recommended that the dosage of DormicumÂ® is decreased gradually (see Drug Abuse and Dependence). Amnesia: DormicumÂ® may cause anterograde amnesia, which occurs most frequently within the first few hours after ingesting the product. In order to reduce the risk, patients should ensure that they are able to have an uninterrupted sleep of 7-8 hours (see Undesirable effects). Residual effects: Provided the oral dose of DormicumÂ® is not larger than 15 mg/day and the patient is assured of at least 7 to 8 hours undisturbed sleep, no residual effect is observed following oral administration of DormicumÂ® tablet in standard patients as confirmed by clinical observations using sensitive pharmacological methods. Psychiatric and â€˜paradoxicalâ€™ reactions: Paradoxical reactions such as restlessness, agitation, irritability, aggressiveness, anxiety, and more rarely, delusion, anger, nightmares, hallucinations, psychoses, inappropriate behaviour and other adverse behavioural effects are known to occur when using benzodiazepines. Should this be so, use of the drug should be discontinued. These effects are more likely to occur in the elderly. Specific patient groups: In elderly and/or debilitated patients, as well as in patients with respiratory or cardiovascular impairment, the recommended dose is 7.5 mg. These patients may be more sensitive to the clinical side effects of midazolam like cardio-respiratory depression. Thus DormicumÂ® should be used very carefully in these patient populations and if needed a lower dose should be considered (see Special Dosage Instructions). Benzodiazepines are not recommended for the primary treatment of psychotic illness. Benzodiazepines should not be used alone to treat depression or anxiety associated with depression as suicide may occur in such patients. Concomitant use of alcohol/CNS depressants: The concomitant use of DormicumÂ® with alcohol or /and CNS depressants should be avoided. Such concomitant use has the potential to increase the clinical effects of DormicumÂ® possibly including severe sedation that could result in coma or death, clinically relevant respiratory and/or cardio-vascular depression (see Interactions with other Medicinal Products and other Forms of Interactions). Medical history of alcohol or drug abuse: DormicumÂ® should be avoided in patients with a medical history of alcohol or drug abuse. Co-medication with drugs that alter CYP3A activity: Midazolam pharmacokinetics is altered in patients receiving concomitantly compounds that inhibit or induce CYP3A. Consequently the clinical and adverse effects may be increased or decreased respectively (see 2.4.5 Interactions with other Medicinal Products and other Forms of Interaction). Lactose intolerance: Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine. Drug Abuse and Dependence Dependence: Use of DormicumÂ® may lead to the development of physical and psychological dependence. The risk of dependence increases with dose and duration of treatment. It is also greater in patients with a medical history of alcohol and/or drug abuse. Withdrawal: Withdrawal symptoms may consist of headaches, diarrhea, muscle pain, extreme anxiety, tension, restlessness, confusion and irritability. In severe cases the following symptoms may occur: derealization, depersonalization, hyperacusis, numbness and tingling of the extremities, hypersensitivity to light, noise and physical contact, hallucinations or convulsions. Since the risk of withdrawal phenomena / rebound insomnia is higher after abrupt discontinuation of treatment, it is recommended that the dosage be decreased gradually {see Dosage and Administration and General (Warnings and Precautions)}. 2.4.3 Ability to Drive and Use Machines Sedation, amnesia, impaired concentration and impaired muscular function adversely affect the ability to drive or to use machines. Prior to receiving DormicumÂ®, the patient should be warned not to drive a vehicle or operate a machine until completely recovered. The physician should decide when these activities may be resumed. If sleep duration is insufficient or alcohol is consumed, the likelihood of impaired alertness may be increased (see 2.4.5 Interactions with other Medicinal Products and other Forms of Interaction). 2.4.4 Laboratory Tests No text. 2.4.5 Interactions with other Medicinal Products and other Forms of Interaction Pharmacokinetic Drug-Drug Interaction (DDI) {See 2.3 Contraindications and 2.4.1 General (Warnings and Precautions)}. Midazolam is almost exclusively metabolized by cytochrome P450 3A (CYP3A4 and CYP3A5). Inhibitors and inducers of CYP3A have the potential to increase and decrease the plasma concentrations and, subsequently, the pharmacodynamic effects of midazolam. No other mechanism than modulation of CYP3A activity has been proven as a source for a clinically relevant pharmacokinetic drug-drug interaction with midazolam. Midazolam is not known to change the pharmacokinetics of other drugs. When co-administered with a CYP3A inhibitor, the clinical effects of oral midazolam may be stronger and also longer lasting and a lower dose may be required. Conversely the effect of midazolam may be weaker and last shorter when co-administered with a CYP3A inducer and a higher dose may be required. In case of CYP3A induction and irreversible inhibition (so-called mechanism-based inhibition), the effect on the pharmacokinetics of midazolam may persist for several days up to several weeks after administration of the CYP3A modulator. Examples of mechanism-based CYP3A inhibitors include antibacterial drugs (e.g., clarithromycin, erythromycin, isoniazid), anti-retrovirals (e.g., HIV protease inhibitors such as ritonavir, including ritonavir-boosted protease inhibitors; delavirdine, calcium channel blockers (e.g., verapamil, diltiazem), tyrosine kinase inhibitors (e.g., imatinib, lapatinib, idelalisib) or the oestrogen receptor modulator raloxifene. Ethinyloestradiol combined with norgestrel or gestodene did not modify exposure to midazolam to a clinically significant degree. Drugs that inhibit CYP3A Classification of CYP3A inhibitors: CYP3A inhibitors can be classified according to the strength of their inhibitory effect and to the importance of the clinical modifications when they are administered concomitantly with oral midazolam. ï‚§ Very strong inhibitors: Midazolam AUC increased &gt; 10-fold. The following drugs fall into thiscategory: e.g., ketoconazole, itraconazole, voriconazole, HIV protease inhibitors includingritonavir-boosted protease inhibitors. Combination of midazolam administered orally with very strong CYP3A inhibitors is contraindicated (see 2.3 Contraindications). ï‚§ Strong inhibitors: Midazolam AUC increased by 5 to 10 fold. The following drugs fall into this category: e.g., high dose clarithromycin, tyrosine kinase inhibitors (such as idelalisib) and the HCV protease inhibitors boceprevir and telaprevir. Concomitant administration of oral midazolam and boceprevir and telaprevir is contraindicated (see 2.3 Contraindications). ï‚§ Moderate inhibitors: Midazolam AUC increased by 2 to 5-fold. The following drugs fall into this category: e.g., fluconazole, clarithromycin, telithromycin, erythromycin, diltiazem, verapamil,nefazodone, NK1 receptor antagonists (aprepitant , netupitant , casopitant, tabimoreline, posaconazole). Patients receiving midazolam with strong or moderate CYP3A inhibitors require careful evaluation because the side effects of midazolam may be potentiated. {see 2.4.1 General (Warnings and Precautions)}. ï‚§ Weak inhibitors: Midazolam AUC increased by 1.25 to &lt; 2-fold. The following drugs and herbals fall into this category: e.g., fentanyl, roxithromycin, cimetidine, ranitidine, fluvoxamine, bicalutamide, propiverine, everolimus, cyclosporine, simeprevir, grapefruit juice, Echinacea purpurea, berberine as also contained in goldenseal. Concomitant administration of midazolam with weak CYP3A inhibitors does not usually lead to a relevant change of midazolam clinical effect. Drugs that induce CYP3A Patients receiving a combination of midazolam with CYP3A inducers may require a higher midazolam dose in particular if midazolam is co-administered with strong CYP3A inducers. Strong CYP3A inducers (â‰¥80% decrease in AUC) include: e.g., rifampin, carbamazepine, phenytoin, enzalutamide and mitotane with its long lasting CYP3A4-inducing effect, while moderate CYP3A inducers (50-80% decrease in AUC) include St Johnâ€™s wort and weak inducers (20-50% decrease in AUC) include efavirenz, clobazam, ticagrelor, vemurafenib, quercetin and Panax ginseng. Pharmacodynamic Drug-Drug Interactions (DDI) The co-administration of midazolam with other sedative / hypnotic agents, including alcohol, is likely to result in increased sedative / hypnotic effects. Examples include opiates / opioids (when they are used as analgesics, antitussives or substitutive treatments), antipsychotics, other benzodiazepines used as anxiolytics or hypnotics, barbiturates, propofol, ketamine, etomidate; sedative antidepressants, antihistamines and centrally acting antihypertensive drugs. Midazolam decreases the minimum alveolar concentration (MAC) of inhalational anaesthetics. Enhanced side effects such as sedation and cardio-respiratory depression may also occur when midazolam is co-administered with any centrally acting depressants including alcohol. Alcohol should be avoided in patients receiving midazolam {see 2.4.1 General (Warnings and Precautions)}. See section 2.7 Overdose for warning of other central nervous system depressants, including alcohol. Drugs increasing alertness / memory like the AchE inhibitor physostigmine reversed the hypnotic effects of midazolam. Similarly, 250 mg of caffeine partly reversed the sedative effect of midazolam.
                </div>
            
                            <div class="col-12">
                    <h4 class="ac-header">Storage Conditions</h4>
                </div>
                <div class="col-12 ac-body">
                    Storage Store in the original container and keep blisters in outer carton in order to protect from light. This medicine should not be used after the expiry date (EXP) shown on the pack.
                </div>
                    </div>
    </div>
</section>

    <!-- Footer -->
    <style>
.radinat_company_list_box{
    background-color: #f8f8f8;
    height: 250px;
    padding: 30px;
    transition: 0.5s;
    z-index: 15;
    width: 100%;
}
.radinat_company_list_box:hover{
    background-color: #ffffff;
}
.border_top_white{
    border-top: 1px solid;
    border-color: #F0EBED;
}
.border_bottom_white{
    border-bottom: 1px solid;
    border-color: #F0EBED;
}
.border_left_white{
    border-left: 1px solid;
    border-color: #F0EBED;
}
.border_right_white{
    border-right: 1px solid;
    border-color: #F0EBED;
}
.radinat_company_list_name{
    font-size: 14px;
    color: #000000;
    width: 100%;
}
</style>

<div class="row" style="margin: 0px; padding: 0px;">
    <div style="width: 100%;margin-top: 10px;margin-bottom: 10px"  class="text-center news-topic aos-init aos-animate" >
        <span style="font-size: 2.5em;font-weight: 300;text-transform: uppercase;border-bottom: 3px solid #ea4545;" >RADIANT AFFILIATE COMPANIES</span>
    </div>

    <div class="row" style="margin: 0px; padding: 0px; width: 100%; z-index: 16;">
        <div class="text-center" style="width: 25%; height: 250px;">
            <a target="_blank" href="../../index.html" style="text-decoration: none;">
                <div class="radinat_company_list_box border_top_white border_bottom_white border_left_white border_right_white d-flex flex-column">
                    <div class="radinat_company_list_name mb-auto p-2">Radiant Pharmaceuticals Limited</div>
                    <div class="text-center">
                        <img src="../../images/company_list/radiant_ph.svg">
                    </div>
                </div>
            </a>
        </div>

        <div class="text-center" style="width: 25%; height: 250px;">
            <a target="_blank" href="http://radiantnutrabd.com/" style="text-decoration: none;">
                <div class="radinat_company_list_box border_top_white border_bottom_white border_right_white d-flex flex-column">
                    <div class="radinat_company_list_name mb-auto p-2">Radiant Nutraceuticals Ltd</div>
                    <div class="text-center">
                        <img src="../../images/company_list/radiant_nu.svg">
                    </div>
                </div>
            </a>
        </div>

        <div class="text-center" style="width: 25%; height: 250px;">
            <a target="_blank" href="http://jenphar.com/" style="text-decoration: none;">
                <div class="radinat_company_list_box border_top_white border_bottom_white d-flex flex-column">
                    <div class="radinat_company_list_name mb-auto p-2">Jenphar Bangladesh Limited</div>
                    <div class="text-center">
                        <img src="../../images/company_list/radiant_jul.svg">
                    </div>
                </div>
            </a>
        </div>

        <div class="text-center" style="width: 25%; height: 250px;">
            <a target="_blank" href="#" style="text-decoration: none;">
                <div class="radinat_company_list_box border_left_white border_bottom_white border_right_white d-flex flex-column">
                    <div class="radinat_company_list_name mb-auto p-2">Radiant Export Import Enterprise</div>
                        <div class="text-center">
                            <img src="../../images/company_list/radiant_eie.svg">
                        </div>
                    </div>
                </a>
            </div>
        </div>
    </div>

    <div class="row" style="margin: 0px; padding: 0px; width: 100%; z-index: 16;">
        <div class="text-center" style="width: 25%; height: 250px;">
            <a target="_blank" href="https://rbclbd.com/" style="text-decoration: none;">
                <div class="radinat_company_list_box border_top_white border_bottom_white border_left_white border_right_white d-flex flex-column">
                    <div class="radinat_company_list_name mb-auto p-2">Radiant Business Consortium Limited</div>
                    <div class="text-center">
                        <img src="../../images/company_list/radinat_bcl.png" width="140px">
                    </div>
                </div>
            </a>
        </div>

        <div class="text-center" style="width: 25%; height: 250px;">
            <a target="_blank" href="http://radiantdistbd.com/" style="text-decoration: none;">
                <div class="radinat_company_list_box border_top_white border_bottom_white border_right_white d-flex flex-column">
                    <div class="radinat_company_list_name mb-auto p-2">Radiant Distribution Limited</div>
                    <div class="text-center">
                        <img src="../../images/company_list/radiant_dl.svg">
                    </div>
                </div>
            </a>
        </div>

        <div class="text-center" style="width: 25%; height: 250px;">
            <a target="_blank" href="http://oncosmolbiol.com/" style="text-decoration: none;">
                <div class="radinat_company_list_box border_top_white border_bottom_white d-flex flex-column">
                    <div class="radinat_company_list_name mb-auto p-2">Radiant Oncos Molbiol Limited</div>
                    <div class="text-center">
                        <img src="../../images/company_list/radiant_oml.svg">
                    </div>
                </div>
            </a>
        </div>

        <div class="text-center" style="width: 25%; height: 250px;">
            <a target="_blank" href="#" style="text-decoration: none;">
                <div class="radinat_company_list_box border_left_white border_bottom_white border_right_white d-flex flex-column">
                    <div class="radinat_company_list_name mb-auto p-2">Shamutshuk Printers Limited</div>
                        <div class="text-center">
                            <img src="../../images/company_list/radiant_spl.svg">
                        </div>
                    </div>
                </a>
            </div>
        </div>
    </div>

    <div class="row" style="margin: 0px; padding: 0px; width: 100%; z-index: 16;">
        <div class="text-center" style="width: 25%; height: 250px;">
            <a target="_blank" href="https://aeromate.com.bd/" style="text-decoration: none;">
                <div class="radinat_company_list_box border_top_white border_bottom_white border_left_white border_right_white d-flex flex-column">
                    <div class="radinat_company_list_name mb-auto p-2">Aeromate Services Limited</div>
                    <div class="text-center">
                        <img src="../../images/company_list/radiant_asl.svg">
                    </div>
                </div>
            </a>
        </div>

        <div class="text-center" style="width: 25%; height: 250px;">
            <a target="_blank" href="https://aerowing.com.bd/" style="text-decoration: none;">
                <div class="radinat_company_list_box border_top_white border_bottom_white border_right_white d-flex flex-column">
                    <div class="radinat_company_list_name mb-auto p-2">AeroWing Aviation Limited</div>
                    <div class="text-center">
                        <img src="../../images/company_list/radiant_aal.svg">
                    </div>
                </div>
            </a>
        </div>

        <div class="text-center" style="width: 25%; height: 250px;">
            <a target="_blank" href="#" style="text-decoration: none;">
                <div class="radinat_company_list_box border_top_white border_bottom_white d-flex flex-column">
                    <div class="radinat_company_list_name mb-auto p-2"></div>
                    <div class="text-center">

                    </div>
                </div>
            </a>
        </div>

        <div style="width: 25%; height: 250px;">
            <a target="_blank" href="#" style="text-decoration: none;">
                <div class="radinat_company_list_box border_left_white border_bottom_white border_right_white d-flex flex-column">
                    <div class="radinat_company_list_name mb-auto p-2"></div>
                        <div class="text-center">

                        </div>
                    </div>
                </a>
            </div>
        </div>
    </div>

</div>

<footer class="footer-area" id="footer-area">
    <div class="container">
        <div class="row">
            <div class="col-lg-3">
                <div class="footer-widget">
                    <a href="../../index.html" class="footer-logo"><img src="../../images/logo-footer.png" alt="logo-footer"></a>
                    <div class="social-media">
                        <ul>
                            <li><a href="https://www.facebook.com/RadiantPharmaceuticalsLimited/" target="_blank"><i class="fab fa-facebook"></i></a></li>
                            <li><a href="https://www.linkedin.com/company/13714589" target="_blank"><i class="fab fa-linkedin-in"></i></a></li>
                        </ul>
                    </div>
                </div>
            </div>
            <div class="col-lg-3">
                <div class="footer-widget">
                    <h4></h4>
                    <ul>
                        <li><a href="../../about-us.html">About Us</a></li>
                        <li><a href="../../products.html">Products</a></li>
                        <li><a href="../../sustainability.html">Sustainability</a></li>
                    </ul>
                </div>
            </div>
            <div class="col-lg-3">
                <div class="footer-widget">
                    <h4></h4>
                    <ul>
                        <li><a href="../../manufacturing.html">Manufacturing Facilities</a></li>
                        <li><a href="../../international-business-overview.html">Global Amplification</a></li>
                        <li><a href="../../csr-our-commitment.html">CSR</a></li>
                    </ul>
                </div>
            </div>
            <div class="col-lg-3">
                <div class="footer-widget mb-0">
                    <h4></h4>
                    <ul>
                        <li><a href="../../pharmacovigilance.html" class="row-body">Pharmacovigilance</a></li>
                        <li><a href="../../career.html" class="row-body">Career</a></li>
                        <li><a href="../../contact-us.html" class="row-body">Contact Us</a></li>
                        <li><a href="https://mail.radiant.com.bd/" target="_blank" class="row-body">Web Mail</a></li>
                    </ul>
                </div>
            </div>
        </div>
    </div>
</footer>
<div class="footer-copyright">
    Copyright © Radiant Pharmaceuticals Limited 2020. All Right Reserved By Radiant Pharmaceuticals Limited.
</div>

<!--
<footer class="footer-area">
    <div class="container">
        <div class="footer-logo text-center">
            <a href="http://www.radiantpharmabd.com"><img src="http://www.radiantpharmabd.com/images/logo-footer.png" alt="logo-footer"></a>
        </div>
        <div class="footer-links text-center">
            <ul>
                <li><a href="http://www.radiantpharmabd.com/about-us">About Us</a></li>
                <li><a href="http://www.radiantpharmabd.com/products">Products</a></li>
                <li><a href="http://www.radiantpharmabd.com/sustainability">Sustainability</a></li>
                <li><a href="http://www.radiantpharmabd.com/manufacturing">Manufacturing Facilities</a></li>
                <li><a href="http://www.radiantpharmabd.com/international-business-overview">Global Business</a></li>
                <li><a href="http://www.radiantpharmabd.com/csr-our-commitment">CSR</a></li>
                <li><a href="http://www.radiantpharmabd.com/pharmacovigilance" class="row-body">Pharmacovigilance</a></li>
                <li><a href="http://www.radiantpharmabd.com/career" class="row-body">Carrer</a></li>
                <li><a href="http://www.radiantpharmabd.com/contact-us" class="row-body">Contact Us</a></li>
            </ul>
        </div>
        <div class="social-media text-center">
            <ul>
                <li><a href="#"><i class="fab fa-facebook"></i></a></li>
                <li><a href="#"><i class="fab fa-linkedin-in"></i></a></li>
            </ul>
        </div>
    </div>
</footer>
<div class="footer-copyright">
    Copyright © Radiant 2020. All Right Reserved By Radiant
</div>
-->

<!--
<footer class="footer">
    <div class="container">
        <div class="row space">
            <div class="col-md-11 offset-md-1">
                <div class="row">
                    <div class="col-6 col-md-4">
                        <a href="http://www.radiantpharmabd.com/about-us" class="row-body">About Us</a>
                        <a href="http://www.radiantpharmabd.com/products" class="row-body">Products</a>
                        <a href="http://www.radiantpharmabd.com/sustainability" class="row-body">Sustainability</a>
                        <a href="http://www.radiantpharmabd.com/manufacturing" class="row-body">Manufacturing Facilities</a>
                        <a href="http://www.radiantpharmabd.com/international-business-overview" class="row-body">Global Business</a>
                        <a href="http://www.radiantpharmabd.com/csr-our-commitment" class="row-body">CSR</a>
                    </div>
                    <div class="col-6 col-md-4">
                        <a href="http://www.radiantpharmabd.com/pharmacovigilance" class="row-body">Pharmacovigilance</a>
                        <a href="http://www.radiantpharmabd.com/career" class="row-body">Carrer</a>
                        <a href="#" class="row-body">Media</a>
                        <a href="http://www.radiantpharmabd.com/contact-us" class="row-body">Contact Us</a>
                    </div>
                    <div class="col-6 col-md-4">
                        <div class="footer-logo">
                            <a href="index.html"> <img src="http://www.radiantpharmabd.com/images/logo-footer.png" alt="logo-footer"></a>
                        </div>
                        <p class="row-title1">Get In Touch</p>
                        <p class="row-body1">Do you have any question or comments about our website, our products or
                            services ?
                        </p>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <div class="footer-social">
        <div class="overlay"></div>
        <p class="col-12 follow-text">
            Follow Us
        </p>
        <div class="col-12 social-networks">
            <a href="#">
                <i class="fab fa-youtube fa-2x fa-fw"></i>
            </a>
            <a href="#">
                <i class="fab fa-facebook fa-2x fa-fw"></i>
            </a>
            <a href="#">
                <i class="fab fa-linkedin-in fa-2x fa-fw"></i>
            </a>
            <a href="#">
                <i class="fab fa-instagram fa-2x fa-fw"></i>
            </a>
            <a href="#">
                <i class="fab fa-twitter fa-2x fa-fw"></i>
            </a>
        </div>
    </div>

    <div class="footer-copyright">
        <a href="#" class="row-body">Copyright © Radiant</a>
        <div class="develop">
            <a href="#" class="row-body">Conditions of Use</a>
            <a href="#" class="row-body">Privacy Statement</a>
            <a href="#" class="row-body">Developers</a>
        </div>
        <a href="#" class="row-body">Site Map</a>
    </div>

</footer>
-->

    <!-- Bootstrap core JavaScript -->
    <script src="../../js/front-end/jquery.min.js"></script>
    <script src="../../js/front-end/bootstrap.bundle.min.js"></script>
    <script src="../../js/front-end/slick.min.js"></script>
    <script src="../../js/front-end/aos.js"></script>
    <script src="../../js/front-end/vendors/superfish/hoverIntent.js"></script>
    <script src="../../js/front-end/vendors/superfish/superfish.min.js"></script>
    <script src="../../js/front-end/custom.js"></script>
    <script>
        (function($){
        /*--===== Preloader Script =====--*/
            $(window).on("load", function () {
                $(".preloader").addClass("loaderout");
            });
        /*--===== End Preloader Script =====--*/
        })(jQuery);
    </script>

    
</body>


<!-- Mirrored from www.radiantpharmabd.com/products/101/details by HTTrack Website Copier/3.x [XR&CO'2014], Sat, 16 Apr 2022 19:26:00 GMT -->
</html>
